{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:56:08Z","timestamp":1792292168724,"version":"4.4.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12035-024-04256-8","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T05:01:52Z","timestamp":1716958912000},"page":"10916-10940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-5926","authenticated-orcid":false,"given":"Raghuraj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archna","family":"Panghal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-2315","authenticated-orcid":false,"given":"Krishna","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-8227","authenticated-orcid":false,"given":"Rahul Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-2103","authenticated-orcid":false,"given":"Jayant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay G.","family":"Namdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"issue":"4","key":"4256_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"L An","year":"2022","unstructured":"An L (2022) 2022 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dementia 18(4):700\u2013789. https:\/\/doi.org\/10.1002\/alz.12638","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"4256_CR2","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1021\/acsomega.2c06939","volume":"8","author":"N Puentes-D\u00edaz","year":"2023","unstructured":"Puentes-D\u00edaz N, Chaparro D, Morales-Morales D, Flores-Gaspar A, Al\u00ed-Torres J (2023) Role of metal cations of copper, Iron, and aluminum and multifunctional ligands in Alzheimer\u2019s disease: experimental and computational insights. ACS omega 8(5):4508\u20134526. https:\/\/doi.org\/10.1021\/acsomega.2c06939","journal-title":"ACS omega"},{"key":"4256_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ccr.2018.03.010","volume":"362","author":"X Wang","year":"2018","unstructured":"Wang X, Wang X, Guo Z (2018) Metal-involved theranostics: An emerging strategy for fighting Alzheimer\u2019s disease. Coord Chem Rev 362:72\u201384. https:\/\/doi.org\/10.1016\/j.ccr.2018.03.010","journal-title":"Coord Chem Rev"},{"key":"4256_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.arr.2016.10.003","volume":"35","author":"P Wang","year":"2017","unstructured":"Wang P, Wang Z-Y (2017) Metal ions influx is a double edged sword for the pathogenesis of Alzheimer\u2019s disease. Ageing Res Rev 35:265\u2013290. https:\/\/doi.org\/10.1016\/j.arr.2016.10.003","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4256_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev.nutr.20.1.627","volume":"20","author":"RS Eisenstein","year":"2000","unstructured":"Eisenstein RS (2000) Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 20(1):627\u2013662. https:\/\/doi.org\/10.1146\/annurev.nutr.20.1.627","journal-title":"Annu Rev Nutr"},{"key":"4256_CR6","doi-asserted-by":"publisher","unstructured":"Vilella A, Daini E, De Benedictis C, Grabrucker A (2020) Targeting metal homeostasis as a therapeutic strategy for Alzheimer\u2019s disease. Exon Publications:83\u201398. https:\/\/doi.org\/10.36255\/exonpublications.alzheimersdisease.2020.ch5","DOI":"10.36255\/exonpublications.alzheimersdisease.2020.ch5"},{"issue":"7","key":"4256_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/brainsci10070460","volume":"10","author":"CA DeBenedictis","year":"2020","unstructured":"DeBenedictis CA, Raab A, Ducie E, Howley S, Feldmann J, Grabrucker AM (2020) Concentrations of essential trace metals in the brain of animal species\u2014a comparative study. Brain Sci 10(7):460. https:\/\/doi.org\/10.3390\/brainsci10070460","journal-title":"Brain Sci"},{"issue":"9","key":"4256_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0753-3322(03)00081-7","volume":"57","author":"H Tapiero","year":"2003","unstructured":"Tapiero H, Tew KD (2003) Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 57(9):399\u2013411. https:\/\/doi.org\/10.1016\/s0753-3322(03)00081-7","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4256_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.exger.2007.10.013","volume":"43","author":"AS Prasad","year":"2008","unstructured":"Prasad AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43(5):370\u2013377. https:\/\/doi.org\/10.1016\/j.exger.2007.10.013","journal-title":"Exp Gerontol"},{"issue":"7","key":"4256_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/jn\/129.7.1251","volume":"129","author":"MM Pe\u00f1a","year":"1999","unstructured":"Pe\u00f1a MM, Lee J, Thiele DJ (1999) A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 129(7):1251\u20131260. https:\/\/doi.org\/10.1093\/jn\/129.7.1251","journal-title":"J Nutr"},{"issue":"2","key":"4256_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2011.10.006","volume":"133","author":"W Zheng","year":"2012","unstructured":"Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther 133(2):177\u2013188. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.10.006","journal-title":"Pharmacol Ther"},{"issue":"12","key":"4256_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","volume":"39","author":"SL Sensi","year":"2018","unstructured":"Sensi SL, Granzotto A, Siotto M, Squitti R (2018) Copper and zinc dysregulation in Alzheimer\u2019s disease. Trends Pharmacol Sci 39(12):1049\u20131063. https:\/\/doi.org\/10.1016\/j.tips.2018.10.001","journal-title":"Trends Pharmacol Sci"},{"key":"4256_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jinorgbio.2018.10.005","volume":"190","author":"J Zhao","year":"2019","unstructured":"Zhao J, Gao W, Yang Z, Li H, Gao Z (2019) Nitration of amyloid-\u03b2 peptide (1\u201342) as a protective mechanism for the amyloid-\u03b2 peptide (1\u201342) against copper ion toxicity. J Inorg Biochem 190:15\u201323. https:\/\/doi.org\/10.1016\/j.jinorgbio.2018.10.005","journal-title":"J Inorg Biochem"},{"issue":"1","key":"4256_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2022.105824","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin Y-L, Liu X-Z, Shen P, Zheng Y-G, Lan X-R, Lu C-B, Wang J-Z (2020) Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 9(1):1\u201313. https:\/\/doi.org\/10.1016\/j.nbd.2022.105824","journal-title":"Transl Neurodegener"},{"key":"4256_CR15","doi-asserted-by":"publisher","unstructured":"Myhre O, Utkilen H, Duale N, Brunborg G, Hofer T, longevity c (2013) Metal dyshomeostasis and inflammation in Alzheimer\u2019s and Parkinson\u2019s diseases: possible impact of environmental exposures. Oxidative medicine 2013. https:\/\/doi.org\/10.1155\/2013\/726954","DOI":"10.1155\/2013\/726954"},{"issue":"7257","key":"4256_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature08300","volume":"460","author":"KJ Waldron","year":"2009","unstructured":"Waldron KJ, Rutherford JC, Ford D, Robinson NJ (2009) Metalloproteins and metal sensing. Nature 460(7257):823\u2013830. https:\/\/doi.org\/10.1038\/nature08300","journal-title":"Nature"},{"issue":"1","key":"4256_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0197-4580(98)00009-8","volume":"19","author":"W Markesbery","year":"1998","unstructured":"Markesbery W, Lovell M (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer\u2019s disease. Neurobiol Aging 19(1):33\u201336. https:\/\/doi.org\/10.1016\/s0197-4580(98)00009-8","journal-title":"Neurobiol Aging"},{"key":"4256_CR18","doi-asserted-by":"publisher","first-page":"126779","DOI":"10.1016\/j.jtemb.2021.126779","volume":"67","author":"KD Fasae","year":"2021","unstructured":"Fasae KD, Abolaji AO, Faloye TR, Odunsi AY, Oyetayo BO, Enya JI, Rotimi JA, Akinyemi RO et al (2021) Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: limitations, and current and future perspectives. J Trace Elem Med Biol 67:126779. https:\/\/doi.org\/10.1016\/j.jtemb.2021.126779","journal-title":"J Trace Elem Med Biol"},{"issue":"2","key":"4256_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.nbd.2015.08.012","volume":"4","author":"AI Bush","year":"2000","unstructured":"Bush AI (2000) Metals and neuroscience. Curr Opin Chem Biol 4(2):184\u2013191. https:\/\/doi.org\/10.1016\/j.nbd.2015.08.012","journal-title":"Curr Opin Chem Biol"},{"issue":"3","key":"4256_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1983.tb04814.x","volume":"41","author":"M Itoh","year":"1983","unstructured":"Itoh M, Ebadi M, Swanson S (1983) The presence of zinc-binding proteins in brain. J Neurochem 41(3):823\u2013829. https:\/\/doi.org\/10.1111\/j.1471-4159.1983.tb04814.x","journal-title":"J Neurochem"},{"key":"4256_CR21","doi-asserted-by":"publisher","unstructured":"Dreosti I (1989) Neurobiology of zinc. In: Zinc in human biology. Springer, pp 235\u2013247. https:\/\/link.springer.com\/chapter\/https:\/\/doi.org\/10.1007\/978-1-4471-3879-2_15","DOI":"10.1007\/978-1-4471-3879-2_15"},{"key":"4256_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000109536","volume":"31","author":"CJ Frederickson","year":"1989","unstructured":"Frederickson CJ (1989) Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol 31:145\u2013238. https:\/\/doi.org\/10.1159\/000109536","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"4256_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.04.003","volume":"92","author":"JA Duce","year":"2010","unstructured":"Duce JA, Bush AI (2010) Biological metals and Alzheimer\u2019s disease: implications for therapeutics and diagnostics. Prog Neurobiol 92(1):1\u201318. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.04.003","journal-title":"Prog Neurobiol"},{"issue":"1","key":"4256_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0165-0270(02)00144-9","volume":"118","author":"R Thompson","year":"2002","unstructured":"Thompson R, Peterson D, Mahoney W, Cramer M, Maliwal BP, Suh SW, Frederickson C, Fierke C et al (2002) Fluorescent zinc indicators for neurobiology. J Neurosci Methods 118(1):63\u201375. https:\/\/doi.org\/10.1016\/s0165-0270(02)00144-9","journal-title":"J Neurosci Methods"},{"issue":"7","key":"4256_CR25","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.3390\/ijms24076867","volume":"24","author":"R Squitti","year":"2023","unstructured":"Squitti R, Reale G, Tondolo V, Crescenti D, Bellini S, Moci M, Caliandro P, Padua L et al (2023) Imbalance of essential metals in traumatic brain injury and its possible link with disorders of consciousness. Int J Mol Sci 24(7):6867. https:\/\/doi.org\/10.3390\/ijms24076867","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4256_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15622975.2021.2013041","volume":"23","author":"J Sarris","year":"2022","unstructured":"Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge JJ, McIntyre RS, Akhondzadeh S, Benedetti F et al (2022) Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry 23(6):424\u2013455. https:\/\/doi.org\/10.1080\/15622975.2021.2013041","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"4256_CR27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/biom10081164","volume":"10","author":"R Squitti","year":"2020","unstructured":"Squitti R, Pal A, Picozza M, Avan A, Ventriglia M, Rongioletti MC, Hoogenraad T (2020) Zinc Therapy in early Alzheimer\u2019s disease: Safety and potential therapeutic efficacy. Biomolecules 10(8):1164. https:\/\/doi.org\/10.3390\/biom10081164","journal-title":"Biomolecules"},{"issue":"4","key":"4256_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","volume":"6","author":"DJ Waggoner","year":"1999","unstructured":"Waggoner DJ, Bartnikas TB, Gitlin JD (1999) The role of copper in neurodegenerative disease. Neurobiol Dis 6(4):221\u2013230. https:\/\/doi.org\/10.1006\/nbdi.1999.0250","journal-title":"Neurobiol Dis"},{"key":"4256_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00775-009-0600-y","volume":"15","author":"YH Hung","year":"2010","unstructured":"Hung YH, Bush AI, Cherny RA (2010) Copper in the brain and Alzheimer\u2019s disease. J Biol Inorg Chem 15:61\u201376. https:\/\/doi.org\/10.1007\/s00775-009-0600-y","journal-title":"J Biol Inorg Chem"},{"issue":"9","key":"4256_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1039\/c0mt00006j","volume":"2","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S, Bhattacharjee A, Hubbard AL (2010) Copper handling machinery of the brain. Metallomics 2(9):596\u2013608. https:\/\/doi.org\/10.1039\/c0mt00006j","journal-title":"Metallomics"},{"key":"4256_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1385\/mn:33:2:81","volume":"33","author":"ML Schlief","year":"2006","unstructured":"Schlief ML, Gitlin JD (2006) Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Mol Neurobiol 33:81\u201390. https:\/\/doi.org\/10.1385\/mn:33:2:81","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4256_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj20141168","volume":"466","author":"CJ Matheou","year":"2015","unstructured":"Matheou CJ, Younan ND, Viles JH (2015) Cu2+ accentuates distinct misfolding of A\u03b2 (1\u201340) and A\u03b2 (1\u201342) peptides, and potentiates membrane disruption. Biochem J 466(2):233\u2013242. https:\/\/doi.org\/10.1042\/bj20141168","journal-title":"Biochem J"},{"key":"4256_CR33","unstructured":"Sastre M, Ritchie CW, Hajji N (2015) Metal ions in Alzheimer\u2019s disease brain. JSM Alzheimer\u2019s Dis Relat Dement 2(1):1014"},{"issue":"2","key":"4256_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s0887-8994(01)00303-4","volume":"25","author":"JR Connor","year":"2001","unstructured":"Connor JR, Menzies SL, Burdo JR, Boyer PJ (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25(2):118\u2013129. https:\/\/doi.org\/10.1016\/s0887-8994(01)00303-4","journal-title":"Pediatr Neurol"},{"issue":"5","key":"4256_CR35","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1021\/cr800447y","volume":"108","author":"EL Que","year":"2008","unstructured":"Que EL, Domaille DW, Chang CJ (2008) Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem Rev 108(5):1517\u20131549. https:\/\/doi.org\/10.1021\/cr800447y","journal-title":"Chem Rev"},{"issue":"5","key":"4256_CR36","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1039\/c4mt00008k","volume":"6","author":"S Pfaender","year":"2014","unstructured":"Pfaender S, Grabrucker AM (2014) Characterization of biometal profiles in neurological disorders. Metallomics 6(5):960\u2013977. https:\/\/doi.org\/10.1039\/c4mt00008k","journal-title":"Metallomics"},{"key":"4256_CR37","doi-asserted-by":"publisher","unstructured":"Walsh D, Minogue A, Sala Frigerio C, Fadeeva J, Wasco W, Selkoe D (2007) The APP family of proteins: similarities and differences. Biochemical Society Transactions, vol 35. Portland Press Ltd. https:\/\/doi.org\/10.1042\/bst0350416","DOI":"10.1042\/bst0350416"},{"issue":"19","key":"4256_CR38","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1074\/jbc.M300629200","volume":"278","author":"KJ Barnham","year":"2003","unstructured":"Barnham KJ, McKinstry WJ, Multhaup G, Galatis D, Morton CJ, Curtain CC, Williamson NA, White AR et al (2003) Structure of the Alzheimer\u2019s disease amyloid precursor protein copper binding domain: a regulator of neuronal copper homeostasis. J Biol Chem 278(19):17401\u201317407. https:\/\/doi.org\/10.1074\/jbc.M300629200","journal-title":"J Biol Chem"},{"issue":"22","key":"4256_CR39","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1016\/S0021-9258(19)85394-2","volume":"268","author":"AI Bush","year":"1993","unstructured":"Bush AI, Multhaup G, Moir RD, Williamson TG, Small DH, Rumble B, Pollwein P, Beyreuther K et al (1993) A novel zinc (II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer\u2019s disease. J Biol Chem 268(22):16109\u201316112. https:\/\/doi.org\/10.1016\/S0021-9258(19)85394-2","journal-title":"J Biol Chem"},{"issue":"1","key":"4256_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1196\/annals.1332.003","volume":"1035","author":"A Venti","year":"2004","unstructured":"Venti A, Giordano T, Eder P, Bush AI, Lahiri DK, Greig NH, Rogers JT (2004) The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5\u2032-untranslated region. Ann N Y Acad Sci 1035(1):34\u201348. https:\/\/doi.org\/10.1196\/annals.1332.003","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4256_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pneurobio.2011.05.001","volume":"158","author":"M Lovell","year":"1998","unstructured":"Lovell M, Robertson J, Teesdale W, Campbell J, Markesbery W (1998) Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 158(1):47\u201352. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.05.001","journal-title":"J Neurol Sci"},{"issue":"16","key":"4256_CR42","doi-asserted-by":"publisher","first-page":"10784","DOI":"10.1074\/jbc.m707109200","volume":"283","author":"V Minicozzi","year":"2008","unstructured":"Minicozzi V, Stellato F, Comai M, Dalla Serra M, Potrich C, Meyer-Klaucke W, Morante S (2008) Identifying the minimal copper-and zinc-binding site sequence in amyloid-\u03b2 peptides. J Biol Chem 283(16):10784\u201310792. https:\/\/doi.org\/10.1074\/jbc.m707109200","journal-title":"J Biol Chem"},{"issue":"3","key":"4256_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30(3):665\u2013676. https:\/\/doi.org\/10.1016\/s0896-6273(01)00317-8","journal-title":"Neuron"},{"issue":"10","key":"4256_CR44","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.chembiol.2017.07.014","volume":"24","author":"ND Telling","year":"2017","unstructured":"Telling ND, Everett J, Collingwood JF, Dobson J, van der Laan G, Gallagher JJ, Wang J et al (2017) Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease. Cell Chem Biol 24(10):1205-1215.e1203. https:\/\/doi.org\/10.1016\/j.chembiol.2017.07.014","journal-title":"Cell Chem Biol"},{"issue":"2","key":"4256_CR45","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1002\/gps.4780","volume":"33","author":"Y Dong","year":"2018","unstructured":"Dong Y, Chen X, Liu Y, Shu Y, Chen T, Xu L, Li M, Guan X (2018) Do low-serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta-analysis of case-control studies. Int J Geriatr Psychiatry 33(2):e257\u2013e263. https:\/\/doi.org\/10.1002\/gps.4780","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"4256_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S1474-4422(23)00414-3","volume":"23","author":"M Chapleau","year":"2024","unstructured":"Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BD et al (2024) Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol 23(2):168\u2013177. https:\/\/doi.org\/10.1016\/S1474-4422(23)00414-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"4256_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2012.1357","volume":"16","author":"R Squitti","year":"2013","unstructured":"Squitti R, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D, Vernieri F, Cassetta E et al (2013) Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer\u2019s disease. Rejuvenation Res 16(1):3\u201310. https:\/\/doi.org\/10.1089\/rej.2012.1357","journal-title":"Rejuvenation Res"},{"key":"4256_CR48","doi-asserted-by":"publisher","first-page":"1260427","DOI":"10.3389\/fnagi.2023.1260427","volume":"15","author":"M Nerattini","year":"2023","unstructured":"Nerattini M, Jett S, Andy C, Carlton C, Zarate C, Boneu C, Battista M, Pahlajani S et al (2023) Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer\u2019s disease and dementia. Front Aging Neurosci 15:1260427. https:\/\/doi.org\/10.3389\/fnagi.2023.1260427","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"4256_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pneurobio.2011.05.001","volume":"94","author":"M Schrag","year":"2011","unstructured":"Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM (2011) Iron, zinc and copper in the Alzheimer\u2019s disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol 94(3):296\u2013306. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.05.001","journal-title":"Prog Neurobiol"},{"issue":"33","key":"4256_CR50","doi-asserted-by":"publisher","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","volume":"274","author":"RA Cherny","year":"1999","unstructured":"Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE et al (1999) Aqueous dissolution of Alzheimer\u2019s disease A\u03b2 amyloid deposits by biometal depletion. J Biol Chem 274(33):23223\u201323228. https:\/\/doi.org\/10.1074\/jbc.274.33.23223","journal-title":"J Biol Chem"},{"key":"4256_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/a:1020731021276","volume":"16","author":"G Perry","year":"2003","unstructured":"Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PL, Siedlak SL, Cash AD, Liu Q et al (2003) Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16:77\u201381. https:\/\/doi.org\/10.1023\/a:1020731021276","journal-title":"Biometals"},{"issue":"4","key":"4256_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/ja076282l","volume":"130","author":"D Noy","year":"2008","unstructured":"Noy D, Solomonov I, Sinkevich O, Arad T, Kjaer K, Sagi I (2008) Zinc-amyloid \u03b2 interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc 130(4):1376\u20131383. https:\/\/doi.org\/10.1021\/ja076282l","journal-title":"J Am Chem Soc"},{"issue":"1","key":"4256_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"issue":"7","key":"4256_CR54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/biom11070960","volume":"11","author":"R Squitti","year":"2021","unstructured":"Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L et al (2021) Copper imbalance in Alzheimer\u2019s disease: meta-analysis of serum, plasma, and brain specimens, and replication study evaluating ATP7B gene variants. Biomolecules 11(7):960. https:\/\/doi.org\/10.3390\/biom11070960","journal-title":"Biomolecules"},{"issue":"1","key":"4256_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JAD-201556","volume":"83","author":"R Squitti","year":"2021","unstructured":"Squitti R, Faller P, Hureau C, Granzotto A, White AR, Kepp KP (2021) Copper imbalance in Alzheimer\u2019s disease and its link with the amyloid hypothesis: towards a combined clinical, chemical, and genetic etiology. J Alzheimers Dis 83(1):23\u201341. https:\/\/doi.org\/10.3233\/JAD-201556","journal-title":"J Alzheimers Dis"},{"key":"4256_CR56","doi-asserted-by":"publisher","unstructured":"Gong L, Sun J, Cong S (2023) Levels of iron and iron-related proteins in Alzheimer\u2019s disease: a systematic review and meta-analysis. Journal of Trace Elements in Medicine Biology 127304. https:\/\/doi.org\/10.1016\/j.jtemb.2023.127304","DOI":"10.1016\/j.jtemb.2023.127304"},{"issue":"7","key":"4256_CR57","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/alz.12282","volume":"17","author":"S Ayton","year":"2021","unstructured":"Ayton S, Portbury S, Kalinowski P, Agarwal P, Diouf I, Schneider JA, Morris MC, Bush AI (2021) Regional brain iron associated with deterioration in Alzheimer\u2019s disease: a large cohort study and theoretical significance. Alzheimer Dementia 17(7):1244\u20131256. https:\/\/doi.org\/10.1002\/alz.12282","journal-title":"Alzheimer Dementia"},{"issue":"1","key":"4256_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141296","volume":"46","author":"M Ventriglia","year":"2015","unstructured":"Ventriglia M, Brewer GJ, Simonelli I, Mariani S, Siotto M, Bucossi S, Squitti R (2015) Zinc in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 46(1):75\u201387. https:\/\/doi.org\/10.3233\/JAD-141296","journal-title":"J Alzheimers Dis"},{"key":"4256_CR59","doi-asserted-by":"publisher","first-page":"130559","DOI":"10.1016\/j.bbagen.2024.130559","volume":"3","author":"A Panghal","year":"1868","unstructured":"Panghal A (1868) Flora SJS (2024) Nanotechnology in the diagnostic and therapy for Alzheimer\u2019s disease. Biochim Biophys Acta 3:130559. https:\/\/doi.org\/10.1016\/j.bbagen.2024.130559","journal-title":"Biochim Biophys Acta"},{"key":"4256_CR60","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH, Khoo CS, Kumar J (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. Front Aging Neurosci 14:742408. https:\/\/doi.org\/10.3389\/fnagi.2022.742408","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"4256_CR61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14(3):457\u2013487. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4256_CR62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20(3):148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"4256_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","volume":"30","author":"Z Chen","year":"2014","unstructured":"Chen Z, Zhong C (2014) Oxidative stress in Alzheimer\u2019s disease. Neurosci Bull 30(2):271\u2013281. https:\/\/doi.org\/10.1007\/s12264-013-1423-y","journal-title":"Neurosci Bull"},{"key":"4256_CR64","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye XY, Xie Y, Xie T (2022) Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev 77:101619. https:\/\/doi.org\/10.1016\/j.arr.2022.101619","journal-title":"Ageing Res Rev"},{"key":"4256_CR65","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.redox.2021.101947","volume":"41","author":"MW Park","year":"2021","unstructured":"Park MW, Cha HW, Kim J, Kim JH, Yang H, Yoon S, Boonpraman N, Yi SS et al (2021) NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer\u2019s diseases. Redox Biol 41:101947. https:\/\/doi.org\/10.1016\/j.redox.2021.101947","journal-title":"Redox Biol"},{"issue":"10","key":"4256_CR66","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/138161208784139693","volume":"14","author":"M Takeuchi","year":"2008","unstructured":"Takeuchi M, Yamagishi S (2008) Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer\u2019s disease. Curr Pharm Des 14(10):973\u2013978. https:\/\/doi.org\/10.2174\/138161208784139693","journal-title":"Curr Pharm Des"},{"issue":"1","key":"4256_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4161\/cam.3.1.7402","volume":"3","author":"A Gella","year":"2009","unstructured":"Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adh Migr 3(1):88\u201393. https:\/\/doi.org\/10.4161\/cam.3.1.7402","journal-title":"Cell Adh Migr"},{"key":"4256_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2019.01.021","volume":"491","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Baquero M, Vento M, Ch\u00e1fer-Peric\u00e1s C (2019) Free radicals in Alzheimer\u2019s disease: lipid peroxidation biomarkers. Clin Chim Acta 491:85\u201390. https:\/\/doi.org\/10.1016\/j.cca.2019.01.021","journal-title":"Clin Chim Acta"},{"issue":"6","key":"4256_CR69","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1046\/j.1471-4159.1997.68062451.x","volume":"68","author":"DA Butterfield","year":"1997","unstructured":"Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, Aksenova M, Bummer PM, Haley BE et al (1997) Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer\u2019s disease. J Neurochem 68(6):2451\u20132457. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.68062451.x","journal-title":"J Neurochem"},{"issue":"6","key":"4256_CR70","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.pharep.2017.06.006","volume":"69","author":"W He","year":"2017","unstructured":"He W, Wang C, Chen Y, He Y, Cai Z (2017) Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-\u03baB signaling, oxidative stress and neuroinflammation. Pharmacol Rep\u202f: PR 69(6):1341\u20131348. https:\/\/doi.org\/10.1016\/j.pharep.2017.06.006","journal-title":"Pharmacol Rep : PR"},{"key":"4256_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms22179461","volume":"22","author":"J Aaseth","year":"2021","unstructured":"Aaseth J, Skalny AV, Roos PM, Alexander J, Aschner M, Tinkov AA (2021) Copper, iron, selenium and lipo-glycemic dysmetabolism in Alzheimer\u2019s disease. Int J Mol Sci 22:17. https:\/\/doi.org\/10.3390\/ijms22179461","journal-title":"Int J Mol Sci"},{"issue":"Pt 6","key":"4256_CR72","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1042\/bst0361282","volume":"36","author":"JT Rogers","year":"2008","unstructured":"Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ et al (2008) Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer\u2019s disease. Biochem Soc Trans 36(Pt 6):1282\u20131287. https:\/\/doi.org\/10.1042\/bst0361282","journal-title":"Biochem Soc Trans"},{"key":"4256_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","volume":"74","author":"L Mezzaroba","year":"2019","unstructured":"Mezzaroba L, Alfieri DF, Colado Sim\u00e3o AN, Vissoci Reiche EM (2019) The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology 74:230\u2013241. https:\/\/doi.org\/10.1016\/j.neuro.2019.07.007","journal-title":"Neurotoxicology"},{"issue":"23","key":"4256_CR74","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1021\/bi0002479","volume":"39","author":"T Miura","year":"2000","unstructured":"Miura T, Suzuki K, Kohata N, Takeuchi H (2000) Metal binding modes of Alzheimer\u2019s amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry 39(23):7024\u20137031. https:\/\/doi.org\/10.1021\/bi0002479","journal-title":"Biochemistry"},{"issue":"12","key":"4256_CR75","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/1071576021000049890","volume":"36","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA (2002) Amyloid beta-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. Rev Free Radic Res 36(12):1307\u20131313. https:\/\/doi.org\/10.1080\/1071576021000049890","journal-title":"Rev Free Radic Res"},{"issue":"49","key":"4256_CR76","doi-asserted-by":"publisher","first-page":"13814","DOI":"10.1021\/jp076213t","volume":"111","author":"W Li","year":"2007","unstructured":"Li W, Zhang J, Su Y, Wang J, Qin M, Wang W (2007) Effects of zinc binding on the conformational distribution of the amyloid-beta peptide based on molecular dynamics simulations. J Phys Chem B 111(49):13814\u201313821. https:\/\/doi.org\/10.1021\/jp076213t","journal-title":"J Phys Chem B"},{"issue":"1","key":"4256_CR77","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","volume":"74","author":"LM Sayre","year":"2000","unstructured":"Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals. J Neurochem 74(1):270\u2013279. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0740270.x","journal-title":"J Neurochem"},{"key":"4256_CR78","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.redox.2020.101494","volume":"32","author":"A Ashraf","year":"2020","unstructured":"Ashraf A, Jeandriens J, Parkes HG, So PW (2020) Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer\u2019s disease: evidence of ferroptosis. Redox Biol 32:101494. https:\/\/doi.org\/10.1016\/j.redox.2020.101494","journal-title":"Redox Biol"},{"key":"4256_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtemb.2016.06.005","volume":"38","author":"T Hofer","year":"2016","unstructured":"Hofer T, Perry G (2016) Nucleic acid oxidative damage in Alzheimer\u2019s disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? J Trace Elem Med Biol 38:1\u20139. https:\/\/doi.org\/10.1016\/j.jtemb.2016.06.005","journal-title":"J Trace Elem Med Biol"},{"key":"4256_CR80","doi-asserted-by":"publisher","first-page":"117253","DOI":"10.1016\/j.jns.2020.117253","volume":"421","author":"V Bhatia","year":"2021","unstructured":"Bhatia V, Sharma S (2021) Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J Neurol Sci 421:117253. https:\/\/doi.org\/10.1016\/j.jns.2020.117253","journal-title":"J Neurol Sci"},{"issue":"4","key":"4256_CR81","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.14037","volume":"143","author":"A Grimm","year":"2017","unstructured":"Grimm A, Eckert A (2017) Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143(4):418\u2013431. https:\/\/doi.org\/10.1111\/jnc.14037","journal-title":"J Neurochem"},{"key":"4256_CR82","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"8","author":"RH Swerdlow","year":"1842","unstructured":"Swerdlow RH, Burns JM (1842) Khan SM (2014) The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochem Biophys Acta 8:1219\u20131231. https:\/\/doi.org\/10.1016\/j.bbadis.2013.09.010","journal-title":"Biochem Biophys Acta"},{"key":"4256_CR83","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464. https:\/\/doi.org\/10.1016\/j.redox.2017.10.014","journal-title":"Redox Biol"},{"issue":"40","key":"4256_CR84","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.2174\/0929867324666170616110111","volume":"25","author":"C Desler","year":"2018","unstructured":"Desler C, Lillenes MS, T\u00f8njum T, Rasmussen LJ (2018) The role of mitochondrial dysfunction in the progression of Alzheimer\u2019s disease. Curr Med Chem 25(40):5578\u20135587. https:\/\/doi.org\/10.2174\/0929867324666170616110111","journal-title":"Curr Med Chem"},{"issue":"3","key":"4256_CR85","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3233\/jad-171008","volume":"63","author":"A Sen","year":"2018","unstructured":"Sen A, Nelson TJ, Alkon DL, Hongpaisan J (2018) Loss in PKC Epsilon causes downregulation of MnSOD and BDNF expression in neurons of Alzheimer\u2019s disease hippocampus. J Alzheim Dis\u202f: JAD 63(3):1173\u20131189. https:\/\/doi.org\/10.3233\/jad-171008","journal-title":"J Alzheim Dis : JAD"},{"issue":"5","key":"4256_CR86","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2353\/ajpath.2006.051223","volume":"168","author":"M Anantharaman","year":"2006","unstructured":"Anantharaman M, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK, St Clair DK (2006) Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH\/NLH X PS-1P264L\/P264L double knock-in mouse model of Alzheimer\u2019s disease. Am J Pathol 168(5):1608\u20131618. https:\/\/doi.org\/10.2353\/ajpath.2006.051223","journal-title":"Am J Pathol"},{"issue":"6","key":"4256_CR87","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/jneurosci.4717-10.2011","volume":"31","author":"J Yao","year":"2011","unstructured":"Yao J, Du H, Yan S, Fang F, Wang C, Lue LF, Guo L, Chen D et al (2011) Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer\u2019s disease. J Neurosci 31(6):2313\u20132320. https:\/\/doi.org\/10.1523\/jneurosci.4717-10.2011","journal-title":"J Neurosci"},{"issue":"10","key":"4256_CR88","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.freeradbiomed.2007.08.011","volume":"43","author":"KS Echtay","year":"2007","unstructured":"Echtay KS (2007) Mitochondrial uncoupling proteins\u2014what is their physiological role? Free Radical Biol Med 43(10):1351\u20131371. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.08.011","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"4256_CR89","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/jad-2006-9209","volume":"9","author":"SM de la Monte","year":"2006","unstructured":"de la Monte SM, Wands JR (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease. J Alzheim Dis\u202f: JAD 9(2):167\u2013181. https:\/\/doi.org\/10.3233\/jad-2006-9209","journal-title":"J Alzheim Dis : JAD"},{"issue":"8","key":"4256_CR90","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1089\/ars.2009.2427","volume":"11","author":"Z Wu","year":"2009","unstructured":"Wu Z, Zhang J, Zhao B (2009) Superoxide anion regulates the mitochondrial free Ca2+ through uncoupling proteins. Antioxid Redox Signal 11(8):1805\u20131818. https:\/\/doi.org\/10.1089\/ars.2009.2427","journal-title":"Antioxid Redox Signal"},{"key":"4256_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fnagi.2019.00337","volume":"11","author":"GR Frost","year":"2019","unstructured":"Frost GR, Jonas LA, Li YM (2019) Friend, foe or both? Immune activity in Alzheimer\u2019s disease. Front Aging Neurosc 11:337. https:\/\/doi.org\/10.3389\/fnagi.2019.00337","journal-title":"Front Aging Neurosc"},{"issue":"3","key":"4256_CR92","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"issue":"Pt A","key":"4256_CR93","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.phrs.2016.09.010","volume":"113","author":"V Villa","year":"2016","unstructured":"Villa V, Thellung S, Bajetto A, Gatta E, Robello M, Novelli F, Tasso B, Tonelli M et al (2016) Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90\u2013231 or lipopolysaccharide. Pharmacol Res 113(Pt A):500\u2013514. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.010","journal-title":"Pharmacol Res"},{"issue":"2","key":"4256_CR94","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol 50(2):534\u2013544. https:\/\/doi.org\/10.1007\/s12035-014-8657-1","journal-title":"Mol Neurobiol"},{"key":"4256_CR95","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1742-2094-9-179","volume":"9","author":"DH Cribbs","year":"2012","unstructured":"Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW (2012) Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 9:179. https:\/\/doi.org\/10.1186\/1742-2094-9-179","journal-title":"J Neuroinflammation"},{"key":"4256_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-3-27","volume":"3","author":"CA Colton","year":"2006","unstructured":"Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3:27. https:\/\/doi.org\/10.1186\/1742-2094-3-27","journal-title":"J Neuroinflammation"},{"issue":"8","key":"4256_CR97","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s12603-019-1240-8","volume":"23","author":"EE Mart\u00ednez Leo","year":"2019","unstructured":"Mart\u00ednez Leo EE, Segura Campos MR (2019) Systemic oxidative stress: a key point in neurodegeneration\u2014a review. J Nutr Health Aging 23(8):694\u2013699. https:\/\/doi.org\/10.1007\/s12603-019-1240-8","journal-title":"J Nutr Health Aging"},{"key":"4256_CR98","doi-asserted-by":"publisher","first-page":"110366","DOI":"10.1016\/j.pnpbp.2021.110366","volume":"111","author":"NH Ashour","year":"2021","unstructured":"Ashour NH, El-Tanbouly DM, El Sayed NS, Khattab MM (2021) Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: involvement of nitric oxide status, A\u03b2 extrusion transporter ABCB1, and reversal by PKA inhibitor H89. Prog Neuropsychopharmacol Biol Psychiatry 111:110366. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110366","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4256_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","volume":"79","author":"M Lyman","year":"2014","unstructured":"Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D (2014) Neuroinflammation: the role and consequences. Neurosci Res 79:1\u201312. https:\/\/doi.org\/10.1016\/j.neures.2013.10.004","journal-title":"Neurosci Res"},{"issue":"3","key":"4256_CR100","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11481-012-9342-7","volume":"7","author":"A Mishra","year":"2012","unstructured":"Mishra A, Kim HJ, Shin AH, Thayer SA (2012) Synapse loss induced by interleukin-1\u03b2 requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol 7(3):571\u2013578. https:\/\/doi.org\/10.1007\/s11481-012-9342-7","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"4256_CR101","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0092-8674(03)00521-x","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114(2):181\u2013190. https:\/\/doi.org\/10.1016\/s0092-8674(03)00521-x","journal-title":"Cell"},{"issue":"6286","key":"4256_CR102","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Sci (New York, NY) 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Sci (New York, NY)"},{"issue":"6","key":"4256_CR103","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheim Dementia 12(6):719\u2013732. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.010","journal-title":"Alzheim Dementia"},{"issue":"3","key":"4256_CR104","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T et al (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153(3):707\u2013720. https:\/\/doi.org\/10.1016\/j.cell.2013.03.030","journal-title":"Cell"},{"issue":"7","key":"4256_CR105","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S et al (2013) CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16(7):848\u2013850. https:\/\/doi.org\/10.1038\/nn.3435","journal-title":"Nat Neurosci"},{"issue":"4","key":"4256_CR106","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH et al (2013) Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78(4):631\u2013643. https:\/\/doi.org\/10.1016\/j.neuron.2013.04.014","journal-title":"Neuron"},{"issue":"19","key":"4256_CR107","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1039\/C4CS00005F","volume":"43","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Korshavn KJ, Kochi A, Derrick JS, Lim MH (2014) Cholesterol and metal ions in Alzheimer\u2019s disease. Chem Soc Rev 43(19):6672\u20136682. https:\/\/doi.org\/10.1039\/C4CS00005F","journal-title":"Chem Soc Rev"},{"issue":"10","key":"4256_CR108","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.18632\/aging.203009","volume":"13","author":"JJ Xu","year":"2021","unstructured":"Xu JJ, Guo S, Xue R, Xiao L, Kou JN, Liu YQ, Han JY, Fu JJ et al (2021) Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats. Aging 13(10):14001\u201314014. https:\/\/doi.org\/10.18632\/aging.203009","journal-title":"Aging"},{"issue":"11","key":"4256_CR109","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao Y, Zhang J, Yang G (2020) Mechanisms of NLRP3 inflammasome activation: its role in the treatment of Alzheimer\u2019s disease. Neurochem Res 45(11):2560\u20132572. https:\/\/doi.org\/10.1007\/s11064-020-03121-z","journal-title":"Neurochem Res"},{"key":"4256_CR110","doi-asserted-by":"publisher","first-page":"570711","DOI":"10.3389\/fneur.2020.570711","volume":"11","author":"KL Hanslik","year":"2020","unstructured":"Hanslik KL, Ulland TK (2020) The role of microglia and the Nlrp3 inflammasome in Alzheimer\u2019s disease. Front Neurol 11:570711. https:\/\/doi.org\/10.3389\/fneur.2020.570711","journal-title":"Front Neurol"},{"issue":"11","key":"4256_CR111","doi-asserted-by":"publisher","first-page":"15620","DOI":"10.18632\/aging.203125","volume":"13","author":"YJ Chiu","year":"2021","unstructured":"Chiu YJ, Lin CH, Lee MC, Hsieh-Li HM, Chen CM, Wu YR, Chang KH, Lee-Chen GJ (2021) Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer\u2019s disease cell and mouse models for neuroprotection and cognitive improvement. Aging 13(11):15620\u201315637. https:\/\/doi.org\/10.18632\/aging.203125","journal-title":"Aging"},{"key":"4256_CR112","doi-asserted-by":"publisher","unstructured":"Fox LM, Yamamoto A (2015) Chapter 7 - macroautophagy of aggregation-prone proteins in neurodegenerative disease. In: Hayat MA (ed) Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. Academic Press, Amsterdam, pp 117\u2013137. https:\/\/doi.org\/10.1016\/B978-0-12-801043-3.00007-8","DOI":"10.1016\/B978-0-12-801043-3.00007-8"},{"key":"4256_CR113","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","volume":"167","author":"H Ashrafian","year":"2021","unstructured":"Ashrafian H, Zadeh EH, Khan RH (2021) Review on Alzheimer\u2019s disease: Inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol 167:382\u2013394. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.11.192","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"4256_CR114","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14(8):837\u2013842. https:\/\/doi.org\/10.1038\/nm1782","journal-title":"Nat Med"},{"issue":"Pt 9","key":"4256_CR115","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/brain\/awn174","volume":"131","author":"NW Hu","year":"2008","unstructured":"Hu NW, Smith IM, Walsh DM, Rowan MJ (2008) Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. Brain 131(Pt 9):2414\u20132424. https:\/\/doi.org\/10.1093\/brain\/awn174","journal-title":"Brain"},{"issue":"28","key":"4256_CR116","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1523\/jneurosci.1344-04.2004","volume":"24","author":"EM Sigurdsson","year":"2004","unstructured":"Sigurdsson EM, Knudsen E, Asuni A, Fitzer-Attas C, Sage D, Quartermain D, Goni F, Frangione B et al (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer\u2019s disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24(28):6277\u20136282. https:\/\/doi.org\/10.1523\/jneurosci.1344-04.2004","journal-title":"J Neurosci"},{"issue":"1","key":"4256_CR117","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118(1):103\u2013113. https:\/\/doi.org\/10.1007\/s00401-009-0522-3","journal-title":"Acta Neuropathol"},{"key":"4256_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","volume":"52","author":"SH Barage","year":"2015","unstructured":"Barage SH, Sonawane KD (2015) Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides 52:1\u201318. https:\/\/doi.org\/10.1016\/j.npep.2015.06.008","journal-title":"Neuropeptides"},{"issue":"2","key":"4256_CR119","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/jad-180802","volume":"68","author":"G Paroni","year":"2019","unstructured":"Paroni G, Bisceglia P, Seripa D (2019) Understanding the amyloid hypothesis in Alzheimer\u2019s disease. J Alzheim Dis\u202f: JAD 68(2):493\u2013510. https:\/\/doi.org\/10.3233\/jad-180802","journal-title":"J Alzheim Dis : JAD"},{"issue":"1","key":"4256_CR120","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D et al (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"4256_CR121","unstructured":"Carma Hassan JC (2024) Biogen discontinues Alzheimer\u2019s medication Aduhelm. Accessed March 18 2024"},{"issue":"3","key":"4256_CR122","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/bj20111924","volume":"443","author":"MS Celej","year":"2012","unstructured":"Celej MS, Sarroukh R, Goormaghtigh E, Fidelio GD, Ruysschaert JM, Raussens V (2012) Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure. Biochem J 443(3):719\u2013726. https:\/\/doi.org\/10.1042\/bj20111924","journal-title":"Biochem J"},{"issue":"1","key":"4256_CR123","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6(1):11\u201322. https:\/\/doi.org\/10.1038\/nrn1587","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"4256_CR124","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1110\/ps.051762406","volume":"15","author":"A Baumketner","year":"2006","unstructured":"Baumketner A, Bernstein SL, Wyttenbach T, Bitan G, Teplow DB, Bowers MT, Shea JE (2006) Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci 15(3):420\u2013428. https:\/\/doi.org\/10.1110\/ps.051762406","journal-title":"Protein Sci"},{"issue":"2","key":"4256_CR125","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/prot.10468","volume":"53","author":"F Ding","year":"2003","unstructured":"Ding F, Borreguero JM, Buldyrey SV, Stanley HE, Dokholyan NV (2003) Mechanism for the alpha-helix to beta-hairpin transition. Proteins 53(2):220\u2013228. https:\/\/doi.org\/10.1002\/prot.10468","journal-title":"Proteins"},{"issue":"8","key":"4256_CR126","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","volume":"68","author":"MA Bruno","year":"2009","unstructured":"Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC (2009) Amyloid \u03b2-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68(8):857\u2013869. https:\/\/doi.org\/10.1097\/NEN.0b013e3181aed9e6","journal-title":"J Neuropathol Exp Neurol"},{"key":"4256_CR127","doi-asserted-by":"publisher","first-page":"1096206","DOI":"10.3389\/fnagi.2023.1096206","volume":"15","author":"FR Sharp","year":"2023","unstructured":"Sharp FR, DeCarli CS, Jin L-W, Zhan X (2023) White matter injury, cholesterol dysmetabolism, and APP\/Abeta dysmetabolism interact to produce Alzheimer\u2019s disease (AD) neuropathology: a hypothesis and review. Front Aging Neurosci 15:1096206. https:\/\/doi.org\/10.3389\/fnagi.2023.1096206","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"4256_CR128","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000358875","volume":"60","author":"A Boutajangout","year":"2014","unstructured":"Boutajangout A, Wisniewski T (2014) Tau-based therapeutic approaches for Alzheimer\u2019s disease\u2014a mini-review. Gerontology 60(5):381\u2013385. https:\/\/doi.org\/10.1159\/000358875","journal-title":"Gerontology"},{"key":"4256_CR129","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B (2020) Role of tau protein in Alzheimer\u2019s disease: the prime pathological player. Int J Biol Macromol 163:1599\u20131617. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.327","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"4256_CR130","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4103\/1673-5374.274329","volume":"15","author":"AA Mamun","year":"2020","unstructured":"Mamun AA, Uddin MS, Mathew B, Ashraf GM (2020) Toxic tau: structural origins of tau aggregation in Alzheimer\u2019s disease. Neural Regen Res 15(8):1417\u20131420. https:\/\/doi.org\/10.4103\/1673-5374.274329","journal-title":"Neural Regen Res"},{"issue":"48","key":"4256_CR131","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.1074\/jbc.RA119.010178","volume":"294","author":"Y Xia","year":"2019","unstructured":"Xia Y, Sorrentino ZA, Kim JD, Strang KH, Riffe CJ, Giasson BI (2019) Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations. J Biol Chem 294(48):18488\u201318503. https:\/\/doi.org\/10.1074\/jbc.RA119.010178","journal-title":"J Biol Chem"},{"issue":"9","key":"4256_CR132","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, Merezhko M, Uronen RL, Huttunen HJ (2020) Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci 77(9):1721\u20131744. https:\/\/doi.org\/10.1007\/s00018-019-03349-1","journal-title":"Cell Mol Life Sci"},{"issue":"7465","key":"4256_CR133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501(7465):45\u201351. https:\/\/doi.org\/10.1038\/nature12481","journal-title":"Nature"},{"issue":"5534","key":"4256_CR134","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Sci (New York, NY) 293(5534):1491\u20131495. https:\/\/doi.org\/10.1126\/science.1062097","journal-title":"Sci (New York, NY)"},{"issue":"48","key":"4256_CR135","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1523\/jneurosci.0172-12.2012","volume":"32","author":"MA Chabrier","year":"2012","unstructured":"Chabrier MA, Blurton-Jones M, Agazaryan AA, Nerhus JL, Martinez-Coria H, LaFerla FM (2012) Soluble a\u03b2 promotes wild-type tau pathology in vivo. J Neurosci 32(48):17345\u201317350. https:\/\/doi.org\/10.1523\/jneurosci.0172-12.2012","journal-title":"J Neurosci"},{"issue":"7","key":"4256_CR136","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/brain\/awy117","volume":"141","author":"SL DeVos","year":"2018","unstructured":"DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D, Moore BD, Bennett RE et al (2018) Tau reduction in the presence of amyloid-\u03b2 prevents tau pathology and neuronal death in vivo. Brain 141(7):2194\u20132212. https:\/\/doi.org\/10.1093\/brain\/awy117","journal-title":"Brain"},{"issue":"5","key":"4256_CR137","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones M, Laferla FM (2006) Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 3(5):437\u2013448. https:\/\/doi.org\/10.2174\/156720506779025242","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"4256_CR138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/s0168-0102(98)00061-3","volume":"31","author":"A Takashima","year":"1998","unstructured":"Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H (1998) Activation of tau protein kinase I\/glycogen synthase kinase-3beta by amyloid beta peptide (25\u201335) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 31(4):317\u2013323. https:\/\/doi.org\/10.1016\/s0168-0102(98)00061-3","journal-title":"Neurosci Res"},{"issue":"9","key":"4256_CR139","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1073\/pnas.092136199","volume":"99","author":"M Rapoport","year":"2002","unstructured":"Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99(9):6364\u20136369. https:\/\/doi.org\/10.1073\/pnas.092136199","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4256_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2010.180","volume":"7","author":"SG Kaler","year":"2011","unstructured":"Kaler SG (2011) ATP7A-related copper transport diseases\u2014emerging concepts and future trends. Nat Rev Neurol 7(1):15\u201329. https:\/\/doi.org\/10.1038\/nrneurol.2010.180","journal-title":"Nat Rev Neurol"},{"key":"4256_CR141","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.neurobiolaging.2014.02.031","volume":"35","author":"R Squitti","year":"2014","unstructured":"Squitti R, Siotto M, Polimanti R (2014) Low-copper diet as a preventive strategy for Alzheimer\u2019s disease. Neurobiol Aging 35:S40\u2013S50. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.02.031","journal-title":"Neurobiol Aging"},{"issue":"11","key":"4256_CR142","doi-asserted-by":"publisher","first-page":"e0139395","DOI":"10.1371\/journal.pone.0139395","volume":"10","author":"JP Guo","year":"2015","unstructured":"Guo JP, Pan JX, Xiong L, Xia WF, Cui S, Xiong WC (2015) Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer\u2019s Disease. PLoS ONE 10(11):e0139395. https:\/\/doi.org\/10.1371\/journal.pone.0139395","journal-title":"PLoS ONE"},{"issue":"12","key":"4256_CR143","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1016\/j.bmc.2018.04.043","volume":"26","author":"X Yang","year":"2018","unstructured":"Yang X, Cai P, Liu Q, Wu J, Yin Y, Wang X, Kong L (2018) Novel 8-hydroxyquinoline derivatives targeting \u03b2-amyloid aggregation, metal chelation and oxidative stress against Alzheimer\u2019s disease. Bioorg Med Chem 26(12):3191\u20133201. https:\/\/doi.org\/10.1016\/j.bmc.2018.04.043","journal-title":"Bioorg Med Chem"},{"key":"4256_CR144","doi-asserted-by":"publisher","first-page":"111393","DOI":"10.1016\/j.jinorgbio.2021.111393","volume":"217","author":"N Pavlidis","year":"2021","unstructured":"Pavlidis N, Kofinas A, Papanikolaou MG, Miras HN, Drouza C, Kalampounias AG, Kabanos TA, Konstandi M et al (2021) Synthesis, characterization and pharmacological evaluation of quinoline derivatives and their complexes with copper(\u0399\u0399) in in vitro cell models of Alzheimer\u2019s disease. J Inorg Biochem 217:111393. https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111393","journal-title":"J Inorg Biochem"},{"issue":"7","key":"4256_CR145","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3390\/ijerph7072745","volume":"7","author":"SJ Flora","year":"2010","unstructured":"Flora SJ, Pachauri V (2010) Chelation in metal intoxication. Int J Environ Res Public Health 7(7):2745\u20132788. https:\/\/doi.org\/10.3390\/ijerph7072745","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"4256_CR146","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1021\/acs.chemrestox.2c00129","volume":"35","author":"SJS Flora","year":"2022","unstructured":"Flora SJS, Jain K, Panghal A, Patwa J (2022) Chemistry, pharmacology, and toxicology of monoisoamyl dimercaptosuccinic acid: a chelating agent for chronic metal poisoning. Chem Res Toxicol 35(10):1701\u20131719. https:\/\/doi.org\/10.1021\/acs.chemrestox.2c00129","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"4256_CR147","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/157488909789104802","volume":"4","author":"R Squitti","year":"2009","unstructured":"Squitti R, Zito G (2009) Anti-copper therapies in Alzheimer\u2019s disease: new concepts. Recent Pat CNS Drug Discovery 4(3):209\u2013219. https:\/\/doi.org\/10.2174\/157488909789104802","journal-title":"Recent Pat CNS Drug Discovery"},{"issue":"94","key":"4256_CR148","doi-asserted-by":"publisher","first-page":"52088","DOI":"10.1039\/C4RA09193K","volume":"4","author":"W Huang","year":"2014","unstructured":"Huang W, Wei W, Shen Z (2014) Drug-like chelating agents: a potential lead for Alzheimer\u2019s disease. RSC Adv 4(94):52088\u201352099. https:\/\/doi.org\/10.1039\/C4RA09193K","journal-title":"RSC Adv"},{"issue":"2\u20133","key":"4256_CR149","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/jsbi.2000.4285","volume":"130","author":"RA Cherny","year":"2000","unstructured":"Cherny RA, Barnham KJ, Lynch T, Volitakis I, Li QX, McLean CA, Multhaup G, Beyreuther K et al (2000) Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer\u2019s disease. J Struct Biol 130(2\u20133):209\u2013216. https:\/\/doi.org\/10.1006\/jsbi.2000.4285","journal-title":"J Struct Biol"},{"key":"4256_CR150","doi-asserted-by":"crossref","unstructured":"McLachlan DR, Smith WL, Kruck TP (1993) Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic drug monitoring 15 (6):602\u2013607. https:\/\/cir.nii.ac.jp\/crid\/1571135650836546304","DOI":"10.1097\/00007691-199312000-00027"},{"issue":"3","key":"4256_CR151","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbadis.2005.06.006","volume":"1741","author":"G Liu","year":"2005","unstructured":"Liu G, Garrett MR, Men P, Zhu X, Perry G, Smith MA (2005) Nanoparticle and other metal chelation therapeutics in Alzheimer disease. Biochem Biophys Acta 1741(3):246\u2013252. https:\/\/doi.org\/10.1016\/j.bbadis.2005.06.006","journal-title":"Biochem Biophys Acta"},{"issue":"8753","key":"4256_CR152","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-b","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. Lancet (London, England) 337(8753):1304\u20131308. https:\/\/doi.org\/10.1016\/0140-6736(91)92978-b","journal-title":"Lancet (London, England)"},{"key":"4256_CR153","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biom12030365","volume":"12","author":"P Kwan","year":"2022","unstructured":"Kwan P, Ho A, Baum L (2022) Effects of Deferasirox in Alzheimer\u2019s Disease and Tauopathy Animal Models. Biomolecules 12:3. https:\/\/doi.org\/10.3390\/biom12030365","journal-title":"Biomolecules"},{"issue":"5","key":"4256_CR154","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","volume":"82","author":"A Yamamoto","year":"2002","unstructured":"Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer\u2019s disease. J Neurochem 82(5):1137\u20131147. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.t01-1-01061.x","journal-title":"J Neurochem"},{"issue":"10","key":"4256_CR155","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nrd2959","volume":"8","author":"KR Brunden","year":"2009","unstructured":"Brunden KR, Trojanowski JQ, Lee VM (2009) Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies. Nat Rev Drug Discovery 8(10):783\u2013793. https:\/\/doi.org\/10.1038\/nrd2959","journal-title":"Nat Rev Drug Discovery"},{"issue":"10","key":"4256_CR156","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/anie.200802621","volume":"48","author":"B Bulic","year":"2009","unstructured":"Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E (2009) Development of tau aggregation inhibitors for Alzheimer\u2019s disease. Angew Chem Int Ed Engl 48(10):1740\u20131752. https:\/\/doi.org\/10.1002\/anie.200802621","journal-title":"Angew Chem Int Ed Engl"},{"issue":"21","key":"4256_CR157","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/jneurosci.21-21-08370.2001","volume":"21","author":"GP Lim","year":"2001","unstructured":"Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21(21):8370\u20138377. https:\/\/doi.org\/10.1523\/jneurosci.21-21-08370.2001","journal-title":"J Neurosci"},{"issue":"1","key":"4256_CR158","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00775-012-0949-1","volume":"18","author":"C Lambert","year":"2013","unstructured":"Lambert C, Beraldo H, Lievre N, Garnier-Suillerot A, Dorlet P, Salerno M (2013) Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation. J Biol Inorg Chem 18(1):59\u201369. https:\/\/doi.org\/10.1007\/s00775-012-0949-1","journal-title":"J Biol Inorg Chem"},{"issue":"27","key":"4256_CR159","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.2174\/1568026616666160216155746","volume":"16","author":"S McKenzie-Nickson","year":"2016","unstructured":"McKenzie-Nickson S, Bush AI, Barnham KJ (2016) Bis(thiosemicarbazone) Metal complexes as therapeutics for neurodegenerative diseases. Curr Top Med Chem 16(27):3058\u20133068. https:\/\/doi.org\/10.2174\/1568026616666160216155746","journal-title":"Curr Top Med Chem"},{"issue":"20","key":"4256_CR160","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1021\/acs.inorgchem.9b00995","volume":"58","author":"C Esmieu","year":"2019","unstructured":"Esmieu C, Guettas D, Conte-Daban A, Sabater L, Faller P, Hureau C (2019) Copper-targeting approaches in Alzheimer\u2019s disease: how to improve the fallouts obtained from in vitro studies. Inorg Chem 58(20):13509\u201313527. https:\/\/doi.org\/10.1021\/acs.inorgchem.9b00995","journal-title":"Inorg Chem"},{"issue":"4","key":"4256_CR161","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1399-3011.2005.00289.x","volume":"66","author":"H Zheng","year":"2005","unstructured":"Zheng H, Youdim MB, Weiner LM, Fridkin M (2005) Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases. J Peptide Res 66(4):190\u2013203. https:\/\/doi.org\/10.1111\/j.1399-3011.2005.00289.x","journal-title":"J Peptide Res"},{"issue":"2","key":"4256_CR162","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1039\/B616085A","volume":"31","author":"C Deraeve","year":"2007","unstructured":"Deraeve C, Piti\u00e9 M, Mazarguil H, Meunier B (2007) Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents. New J Chem 31(2):193\u2013195. https:\/\/doi.org\/10.1039\/B616085A","journal-title":"New J Chem"},{"issue":"6","key":"4256_CR163","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/s0197-4580(02)00120-3","volume":"23","author":"AI Bush","year":"2002","unstructured":"Bush AI (2002) Metal complexing agents as therapies for Alzheimer\u2019s disease. Neurobiol Aging 23(6):1031\u20131038. https:\/\/doi.org\/10.1016\/s0197-4580(02)00120-3","journal-title":"Neurobiol Aging"},{"issue":"12","key":"4256_CR164","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60(12):1685\u20131691. https:\/\/doi.org\/10.1001\/archneur.60.12.1685","journal-title":"Arch Neurol"},{"issue":"4","key":"4256_CR165","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/med.20148","volume":"29","author":"S Bolognin","year":"2009","unstructured":"Bolognin S, Drago D, Messori L, Zatta P (2009) Chelation therapy for neurodegenerative diseases. Med Res Rev 29(4):547\u2013570. https:\/\/doi.org\/10.1002\/med.20148","journal-title":"Med Res Rev"},{"issue":"1","key":"4256_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/v10007-011-0006-6","volume":"61","author":"A Budimir","year":"2011","unstructured":"Budimir A (2011) Metal ions, Alzheimer\u2019s disease and chelation therapy. Acta Pharm (Zagreb, Croatia) 61(1):1\u201314. https:\/\/doi.org\/10.2478\/v10007-011-0006-6","journal-title":"Acta Pharm (Zagreb, Croatia)"},{"issue":"8","key":"4256_CR167","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00775-019-01712-y","volume":"24","author":"GJ Yang","year":"2019","unstructured":"Yang GJ, Liu H, Ma DL, Leung CH (2019) Rebalancing metal dyshomeostasis for Alzheimer\u2019s disease therapy. J Biol Inorg Chem 24(8):1159\u20131170. https:\/\/doi.org\/10.1007\/s00775-019-01712-y","journal-title":"J Biol Inorg Chem"},{"issue":"2","key":"4256_CR168","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1476-5381.2011.01221.x","volume":"163","author":"VB Kenche","year":"2011","unstructured":"Kenche VB, Barnham KJ (2011) Alzheimer\u2019s disease & metals: therapeutic opportunities. Br J Pharmacol 163(2):211\u2013219. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01221.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4256_CR169","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/jad-2009-1068","volume":"17","author":"ML Hegde","year":"2009","unstructured":"Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, Poddar P, Srinivas P, Sambamurti K et al (2009) Challenges associated with metal chelation therapy in Alzheimer\u2019s disease. J Alzheim Dis\u202f: JAD 17(3):457\u2013468. https:\/\/doi.org\/10.3233\/jad-2009-1068","journal-title":"J Alzheim Dis : JAD"},{"issue":"9","key":"4256_CR170","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s1474-4422(07)70195-3","volume":"6","author":"H Kavirajan","year":"2007","unstructured":"Kavirajan H, Schneider LS (2007) Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 6(9):782\u2013792. https:\/\/doi.org\/10.1016\/s1474-4422(07)70195-3","journal-title":"Lancet Neurol"},{"issue":"13","key":"4256_CR171","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s00018-005-5073-8","volume":"62","author":"P Zatta","year":"2005","unstructured":"Zatta P, Raso M, Zambenedetti P, Wittkowski W, Messori L, Piccioli F, Mauri PL, Beltramini M (2005) Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment. Cell Mol Life Sci 62(13):1502\u20131513. https:\/\/doi.org\/10.1007\/s00018-005-5073-8","journal-title":"Cell Mol Life Sci"},{"key":"4256_CR172","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/biology11020212","volume":"11","author":"P Pritam","year":"2022","unstructured":"Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha AK, Jha NK, Villa C et al (2022) Antioxidants in Alzheimer\u2019s disease: current therapeutic significance and future prospects. Biology 11:2. https:\/\/doi.org\/10.3390\/biology11020212","journal-title":"Biology"},{"key":"4256_CR173","doi-asserted-by":"publisher","unstructured":"Baptista FI, Henriques AG, Silva AM, Wiltfang J, da Cruz e Silva OA (2014) Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. ACS Chem Neurosc 5 (2):83-92 https:\/\/doi.org\/10.1021\/cn400213r","DOI":"10.1021\/cn400213r"},{"issue":"4","key":"4256_CR174","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12640-014-9466-z","volume":"26","author":"SK Singh","year":"2014","unstructured":"Singh SK, Gaur R, Kumar A, Fatima R, Mishra L, Srikrishna S (2014) The flavonoid derivative 2-(4\u2019 Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against A\u03b242-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies. Neurotox Res 26(4):331\u2013350. https:\/\/doi.org\/10.1007\/s12640-014-9466-z","journal-title":"Neurotox Res"},{"issue":"4","key":"4256_CR175","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/s0891-5849(00)00498-6","volume":"30","author":"K Ishige","year":"2001","unstructured":"Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biol Med 30(4):433\u2013446. https:\/\/doi.org\/10.1016\/s0891-5849(00)00498-6","journal-title":"Free Radical Biol Med"},{"key":"4256_CR176","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ijms20040879","volume":"20","author":"A Lloret","year":"2019","unstructured":"Lloret A, Esteve D, Monllor P, Cervera-Ferri A, Lloret A (2019) The Effectiveness of vitamin E treatment in Alzheimer\u2019s disease. Int J Mol Sci 20:4. https:\/\/doi.org\/10.3390\/ijms20040879","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4256_CR177","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/01.wnl.0000028688.75881.12","volume":"59","author":"SM Zhang","year":"2002","unstructured":"Zhang SM, Hern\u00e1n MA, Chen H, Spiegelman D, Willett WC, Ascherio A (2002) Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 59(8):1161\u20131169. https:\/\/doi.org\/10.1212\/01.wnl.0000028688.75881.12","journal-title":"Neurology"},{"issue":"12","key":"4256_CR178","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.3390\/nu6125453","volume":"6","author":"G La Fata","year":"2014","unstructured":"La Fata G, Weber P, Mohajeri MH (2014) Effects of vitamin E on cognitive performance during ageing and in Alzheimer\u2019s disease. Nutrients 6(12):5453\u20135472. https:\/\/doi.org\/10.3390\/nu6125453","journal-title":"Nutrients"},{"issue":"2","key":"4256_CR179","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cns.13095","volume":"25","author":"N Kandiah","year":"2019","unstructured":"Kandiah N, Ong PA, Yuda T, Ng LL, Mamun K, Merchant RA, Chen C, Dominguez J et al (2019) Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: expert consensus on the use of Ginkgo biloba extract, EGb 761(\u00ae). CNS Neurosci Ther 25(2):288\u2013298. https:\/\/doi.org\/10.1111\/cns.13095","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"4256_CR180","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/jnc.15253","volume":"157","author":"CM Cowan","year":"2021","unstructured":"Cowan CM, Sealey MA, Mudher A (2021) Suppression of tau-induced phenotypes by vitamin E demonstrates the dissociation of oxidative stress and phosphorylation in mechanisms of tau toxicity. J Neurochem 157(3):684\u2013694. https:\/\/doi.org\/10.1111\/jnc.15253","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"4256_CR181","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00429-009-0234-4","volume":"214","author":"K Iijima-Ando","year":"2010","unstructured":"Iijima-Ando K, Iijima K (2010) Transgenic Drosophila models of Alzheimer\u2019s disease and tauopathies. Brain Struct Funct 214(2\u20133):245\u2013262. https:\/\/doi.org\/10.1007\/s00429-009-0234-4","journal-title":"Brain Struct Funct"},{"issue":"3","key":"4256_CR182","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40520-019-01209-3","volume":"32","author":"M Casati","year":"2020","unstructured":"Casati M, Boccardi V, Ferri E, Bertagnoli L, Bastiani P, Ciccone S, Mansi M, Scamosci M et al (2020) Vitamin E and Alzheimer\u2019s disease: the mediating role of cellular aging. Aging Clin Exp Res 32(3):459\u2013464. https:\/\/doi.org\/10.1007\/s40520-019-01209-3","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"4256_CR183","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/exnr.2001.7684","volume":"170","author":"I Veinbergs","year":"2001","unstructured":"Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E (2001) Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp Neurol 170(1):15\u201326. https:\/\/doi.org\/10.1006\/exnr.2001.7684","journal-title":"Exp Neurol"},{"issue":"2","key":"4256_CR184","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1515\/revneuro.1999.10.2.141","volume":"10","author":"DA Butterfield","year":"1999","unstructured":"Butterfield DA, Koppal T, Subramaniam R, Yatin S (1999) Vitamin E as an antioxidant\/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer\u2019s disease. Rev Neurosci 10(2):141\u2013149. https:\/\/doi.org\/10.1515\/revneuro.1999.10.2.141","journal-title":"Rev Neurosci"},{"issue":"1","key":"4256_CR185","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1460-9568.1999.00408.x","volume":"11","author":"K Yamada","year":"1999","unstructured":"Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T (1999) Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1\u201342)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11(1):83\u201390. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00408.x","journal-title":"Eur J Neurosci"},{"issue":"17","key":"4256_CR186","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/nejm199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study. New Engl J Med 336(17):1216\u20131222. https:\/\/doi.org\/10.1056\/nejm199704243361704","journal-title":"New Engl J Med"},{"issue":"8","key":"4256_CR187","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/s0955-2863(02)00205-x","volume":"13","author":"D Butterfield","year":"2002","unstructured":"Butterfield D, Castegna A, Pocernich C, Drake J, Scapagnini G, Calabrese V (2002) Nutritional approaches to combat oxidative stress in Alzheimer\u2019s disease. J Nutr Biochem 13(8):444. https:\/\/doi.org\/10.1016\/s0955-2863(02)00205-x","journal-title":"J Nutr Biochem"},{"issue":"12","key":"4256_CR188","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1007\/s11064-014-1481-1","volume":"40","author":"R Dringen","year":"2015","unstructured":"Dringen R, Brandmann M, Hohnholt MC, Blumrich EM (2015) Glutathione-dependent detoxification processes in astrocytes. Neurochem Res 40(12):2570\u20132582. https:\/\/doi.org\/10.1007\/s11064-014-1481-1","journal-title":"Neurochem Res"},{"key":"4256_CR189","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/antiox9100909","volume":"9","author":"M Mar\u00ed","year":"2020","unstructured":"Mar\u00ed M, de Gregorio E, de Dios C, Roca-Agujetas V, Cucarull B, Tutusaus A, Morales A, Colell A (2020) Mitochondrial Glutathione: Recent Insights and Role in Disease. Antioxid (Basel, Switzerland) 9:10. https:\/\/doi.org\/10.3390\/antiox9100909","journal-title":"Antioxid (Basel, Switzerland)"},{"issue":"17","key":"4256_CR190","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1093\/hmg\/ddt201","volume":"22","author":"E Barbero-Camps","year":"2013","unstructured":"Barbero-Camps E, Fern\u00e1ndez A, Mart\u00ednez L, Fern\u00e1ndez-Checa JC, Colell A (2013) APP\/PS1 mice overexpressing SREBP-2 exhibit combined A\u03b2 accumulation and tau pathology underlying Alzheimer\u2019s disease. Hum Mol Genet 22(17):3460\u20133476. https:\/\/doi.org\/10.1093\/hmg\/ddt201","journal-title":"Hum Mol Genet"},{"key":"4256_CR191","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-7-13","volume":"7","author":"M Allen","year":"2012","unstructured":"Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS et al (2012) Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener 7:13. https:\/\/doi.org\/10.1186\/1750-1326-7-13","journal-title":"Mol Neurodegener"},{"key":"4256_CR192","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fnins.2020.00494","volume":"14","author":"S Naqvi","year":"2020","unstructured":"Naqvi S, Panghal A, Flora SJS (2020) Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front Neurosci 14:494. https:\/\/doi.org\/10.3389\/fnins.2020.00494","journal-title":"Front Neurosci"},{"issue":"1","key":"4256_CR193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbagen.2005.09.008","volume":"1760","author":"QY Wei","year":"2006","unstructured":"Wei QY, Chen WF, Zhou B, Yang L, Liu ZL (2006) Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochem Biophys Acta 1760(1):70\u201377. https:\/\/doi.org\/10.1016\/j.bbagen.2005.09.008","journal-title":"Biochem Biophys Acta"},{"issue":"4","key":"4256_CR194","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/jad-2004-6403","volume":"6","author":"L Baum","year":"2004","unstructured":"Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J Alzheim Dis 6(4):367\u2013377. https:\/\/doi.org\/10.3233\/jad-2004-6403. (discussion 443-369)","journal-title":"J Alzheim Dis"},{"issue":"3","key":"4256_CR195","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.toxlet.2007.03.011","volume":"170","author":"T Nishinaka","year":"2007","unstructured":"Nishinaka T, Ichijo Y, Ito M, Kimura M, Katsuyama M, Iwata K, Miura T, Terada T et al (2007) Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Toxicol Lett 170(3):238\u2013247. https:\/\/doi.org\/10.1016\/j.toxlet.2007.03.011","journal-title":"Toxicol Lett"},{"key":"4256_CR196","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.phrs.2017.08.004","volume":"124","author":"MM Serafini","year":"2017","unstructured":"Serafini MM, Catanzaro M, Rosini M, Racchi M, Lanni C (2017) Curcumin in Alzheimer\u2019s disease: Can we think to new strategies and perspectives for this molecule? Pharmacol Res 124:146\u2013155. https:\/\/doi.org\/10.1016\/j.phrs.2017.08.004","journal-title":"Pharmacol Res"},{"issue":"5","key":"4256_CR197","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1471-4159.2004.02800.x","volume":"91","author":"RK Giri","year":"2004","unstructured":"Giri RK, Rajagopal V, Kalra VK (2004) Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91(5):1199\u20131210. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02800.x","journal-title":"J Neurochem"},{"issue":"6","key":"4256_CR198","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s0197-4580(01)00300-1","volume":"22","author":"SA Frautschy","year":"2001","unstructured":"Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22(6):993\u20131005. https:\/\/doi.org\/10.1016\/s0197-4580(01)00300-1","journal-title":"Neurobiol Aging"},{"key":"4256_CR199","doi-asserted-by":"publisher","unstructured":"Singh SK, Srikrishna S, Castellani RJ, Perry G (2017) Antioxidants in the\u00a0Prevention and Treatment of Alzheimer\u2019s Disease. In: Al-Gubory KH, Laher I (eds) Nutritional antioxidant therapies: treatments and perspectives. Springer International Publishing, Cham, pp 523\u2013553. https:\/\/doi.org\/10.1007\/978-3-319-67625-8_20","DOI":"10.1007\/978-3-319-67625-8_20"},{"key":"4256_CR200","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/molecules23092357","volume":"23","author":"K Ide","year":"2018","unstructured":"Ide K, Matsuoka N, Yamada H, Furushima D, Kawakami K (2018) Effects of tea catechins on Alzheimer\u2019s disease: recent updates and perspectives. Mol (Basel, Switzerland) 23:9. https:\/\/doi.org\/10.3390\/molecules23092357","journal-title":"Mol (Basel, Switzerland)"},{"issue":"5","key":"4256_CR201","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/s0024-3205(01)01438-2","volume":"70","author":"YT Choi","year":"2001","unstructured":"Choi YT, Jung CH, Lee SR, Bae JH, Baek WK, Suh MH, Park J, Park CW et al (2001) The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci 70(5):603\u2013614. https:\/\/doi.org\/10.1016\/s0024-3205(01)01438-2","journal-title":"Life Sci"},{"issue":"9","key":"4256_CR202","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jnutbio.2007.08.008","volume":"19","author":"AM Haque","year":"2008","unstructured":"Haque AM, Hashimoto M, Katakura M, Hara Y, Shido O (2008) Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J Nutr Biochem 19(9):619\u2013626. https:\/\/doi.org\/10.1016\/j.jnutbio.2007.08.008","journal-title":"J Nutr Biochem"},{"issue":"1","key":"4256_CR203","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bandc.2007.10.003","volume":"67","author":"T Kaur","year":"2008","unstructured":"Kaur T, Pathak CM, Pandhi P, Khanduja KL (2008) Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 67(1):25\u201330. https:\/\/doi.org\/10.1016\/j.bandc.2007.10.003","journal-title":"Brain Cogn"},{"key":"4256_CR204","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gon\u00e7alves PR, Sakai JT, Mendes PFS et al (2018) Neuroprotective mechanisms of Resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 2018:8152373. https:\/\/doi.org\/10.1155\/2018\/8152373","journal-title":"Oxid Med Cell Longev"},{"key":"4256_CR205","doi-asserted-by":"publisher","first-page":"8983752","DOI":"10.1155\/2019\/8983752","volume":"2019","author":"D Kong","year":"2019","unstructured":"Kong D, Yan Y, He XY, Yang H, Liang B, Wang J, He Y, Ding Y et al (2019) Effects of resveratrol on the mechanisms of antioxidants and estrogen in Alzheimer\u2019s disease. Biomed Res Int 2019:8983752. https:\/\/doi.org\/10.1155\/2019\/8983752","journal-title":"Biomed Res Int"},{"key":"4256_CR206","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","volume":"12","author":"BD Arbo","year":"2020","unstructured":"Arbo BD, Andr\u00e9-Miral C, Nasre-Nasser RG, Schimith LE, Santos MG, Costa-Silva D, Muccillo-Baisch AL, Hort MA (2020) Resveratrol derivatives as potential treatments for Alzheimer\u2019s and Parkinson\u2019s disease. Front Aging Neurosci 12:103. https:\/\/doi.org\/10.3389\/fnagi.2020.00103","journal-title":"Front Aging Neurosci"},{"key":"4256_CR207","doi-asserted-by":"publisher","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Archives of neurology 60 (12):1685\u20131691. https:\/\/www.doi.org\/https:\/\/doi.org\/10.1001\/archneur.60.12.1685","DOI":"10.1001\/archneur.60.12.1685"},{"issue":"17","key":"4256_CR208","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1089\/ars.2012.5158","volume":"19","author":"C-Y Wang","year":"2013","unstructured":"Wang C-Y, Xie J-W, Xu Y, Wang T, Cai J-H, Wang X, Zhao B-L, An L et al (2013) Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE\/RAGE\/NF-\u03baB pathway in a transgenic mouse model of Alzheimer\u2019s disease. Antioxid Redox Signal 19(17):2024\u20132039. https:\/\/doi.org\/10.1089\/ars.2012.5158","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4256_CR209","doi-asserted-by":"publisher","first-page":"13763","DOI":"10.1038\/s41598-017-12800-x","volume":"7","author":"W Xu","year":"2017","unstructured":"Xu W, Xu Q, Cheng H, Tan X (2017) The efficacy and pharmacological mechanism of Zn7MT3 to protect against Alzheimer\u2019s disease. Sci Rep 7(1):13763. https:\/\/doi.org\/10.1038\/s41598-017-12800-x","journal-title":"Sci Rep"},{"issue":"11\u201312","key":"4256_CR210","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.exger.2004.08.016","volume":"39","author":"A Dedeoglu","year":"2004","unstructured":"Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li X, Moir RD et al (2004) Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer\u2019s amyloidogenesis. Exp Gerontol 39(11\u201312):1641\u20131649. https:\/\/doi.org\/10.1016\/j.exger.2004.08.016","journal-title":"Exp Gerontol"},{"issue":"8753","key":"4256_CR211","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DC McLachlan","year":"1991","unstructured":"McLachlan DC, Kruck T, Kalow W, Andrews D, Dalton A, Bell M, Smith W (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. The Lancet 337(8753):1304\u20131308. https:\/\/doi.org\/10.1016\/0140-6736(91)92978-B","journal-title":"The Lancet"},{"issue":"2","key":"4256_CR212","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-2010-1390","volume":"20","author":"NG Faux","year":"2010","unstructured":"Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L et al (2010) PBT2 rapidly improves cognition in Alzheimer\u2019s disease: additional phase II analyses. J Alzheim Dis 20(2):509\u2013516. https:\/\/doi.org\/10.3233\/JAD-2010-1390","journal-title":"J Alzheim Dis"},{"issue":"10","key":"4256_CR213","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.neurobiolaging.2004.01.005","volume":"25","author":"J-Y Lee","year":"2004","unstructured":"Lee J-Y, Friedman JE, Angel I, Kozak A, Koh J-Y (2004) The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human \u03b2-amyloid precursor protein transgenic mice. Neurobiol Aging 25(10):1315\u20131321. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.01.005","journal-title":"Neurobiol Aging"},{"key":"4256_CR214","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.npep.2018.06.002","volume":"71","author":"I Cacciatore","year":"2018","unstructured":"Cacciatore I, Marinelli L, Di Stefano A, Di Marco V, Orlando G, Gabriele M, Gatta DMP, Ferrone A et al (2018) Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases. Neuropeptides 71:11\u201320. https:\/\/doi.org\/10.1016\/j.npep.2018.06.002","journal-title":"Neuropeptides"},{"issue":"3","key":"4256_CR215","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.foodchem.2012.06.016","volume":"135","author":"J Carrasco-Castilla","year":"2012","unstructured":"Carrasco-Castilla J, Hern\u00e1ndez-\u00c1lvarez AJ, Jim\u00e9nez-Mart\u00ednez C, Jacinto-Hern\u00e1ndez C, Alaiz M, Gir\u00f3n-Calle J, Vioque J, D\u00e1vila-Ortiz G (2012) Antioxidant and metal chelating activities of peptide fractions from phaseolin and bean protein hydrolysates. Food Chem 135(3):1789\u20131795. https:\/\/doi.org\/10.1016\/j.foodchem.2012.06.016","journal-title":"Food Chem"},{"issue":"9","key":"4256_CR216","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1021\/jf950833m","volume":"44","author":"H-M Chen","year":"1996","unstructured":"Chen H-M, Muramoto K, Yamauchi F, Nokihara K (1996) Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J Agric 44(9):2619\u20132623. https:\/\/doi.org\/10.1021\/jf950833m","journal-title":"J Agric"},{"issue":"4","key":"4256_CR217","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1021\/ic101965j","volume":"50","author":"A El Ghazouani","year":"2011","unstructured":"El Ghazouani A, Basle A, Firbank SJ, Knapp CW, Gray J, Graham DW, Dennison C (2011) Copper-binding properties and structures of methanobactins from Methylosinus trichosporium OB3b. Inorg Chem 50(4):1378\u20131391. https:\/\/doi.org\/10.1021\/ic101965j","journal-title":"Inorg Chem"},{"issue":"12","key":"4256_CR218","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1007\/s13361-017-1778-9","volume":"28","author":"JW McCabe","year":"2017","unstructured":"McCabe JW, Vangala R, Angel LA (2017) Binding selectivity of methanobactin from Methylosinus trichosporium OB3b for copper (I), silver (I), zinc (II), nickel (II), cobalt (II), manganese (II), lead (II), and iron (II). J Am Soc Mass Spectrom 28(12):2588\u20132601. https:\/\/doi.org\/10.1007\/s13361-017-1778-9","journal-title":"J Am Soc Mass Spectrom"},{"key":"4256_CR219","doi-asserted-by":"publisher","first-page":"213594","DOI":"10.1016\/j.bioadv.2023.213594","volume":"154","author":"K Jadhav","year":"2023","unstructured":"Jadhav K, Jhilta A, Singh R, Ray E, Sharma N, Shukla R, Singh AK, Verma RK (2023) Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation. Biomaterials Advances 154:213594. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213594","journal-title":"Biomaterials Advances"},{"issue":"13","key":"4256_CR220","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2174\/1381612829666230406102935","volume":"29","author":"R Singh","year":"2023","unstructured":"Singh R, Jadhav K, Vaghasiya K, Ray E, Shukla R, Verma RK (2023) New generation smart drug delivery systems for rheumatoid arthritis. Curr Pharm Des 29(13):984\u20131001. https:\/\/doi.org\/10.2174\/1381612829666230406102935","journal-title":"Curr Pharm Des"},{"key":"4256_CR221","doi-asserted-by":"publisher","unstructured":"Jadhav K, Ray E, Vaghasiya K, Verma RK (2022) Neurodegenerative disorders due to inhalation of various small particles. In: Nanomedical Drug Delivery for Neurodegenerative Diseases. Elsevier, pp 41\u201354. https:\/\/doi.org\/10.1016\/B978-0-323-85544-0.00010-1","DOI":"10.1016\/B978-0-323-85544-0.00010-1"},{"key":"4256_CR222","doi-asserted-by":"publisher","unstructured":"Shukla R, Thok K, Alam I, Singh R (2020) Nanophytomedicine market: global opportunity analysis and industry forecast. Nanophytomedicine: Concept to Clinic:19\u201331. https:\/\/link.springer.com\/chapter\/https:\/\/doi.org\/10.1007\/978-981-15-4909-0_2","DOI":"10.1007\/978-981-15-4909-0_2"},{"key":"4256_CR223","doi-asserted-by":"publisher","first-page":"112027","DOI":"10.1016\/j.msec.2021.112027","volume":"123","author":"K Vaghasiya","year":"2021","unstructured":"Vaghasiya K, Ray E, Singh R, Jadhav K, Sharma A, Khan R, Katare OP, Verma RK (2021) Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy. Mater Sci Eng: C 123:112027. https:\/\/doi.org\/10.1016\/j.msec.2021.112027","journal-title":"Mater Sci Eng: C"},{"issue":"14","key":"4256_CR224","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.3390\/molecules26144301","volume":"26","author":"Y Huang","year":"2021","unstructured":"Huang Y, Chang Y, Liu L, Wang J (2021) Nanomaterials for modulating the aggregation of \u03b2-amyloid peptides. Mol (Basel, Switzerland) 26(14):4301. https:\/\/doi.org\/10.3390\/molecules26144301","journal-title":"Mol (Basel, Switzerland)"},{"issue":"3","key":"4256_CR225","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neulet.2006.07.020","volume":"406","author":"G Liu","year":"2006","unstructured":"Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA (2006) Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci Lett 406(3):189\u2013193. https:\/\/doi.org\/10.1016\/j.neulet.2006.07.020","journal-title":"Neurosci Lett"},{"key":"4256_CR226","doi-asserted-by":"publisher","unstructured":"Huang Q, Jiang C, Xia X, Wang Y, Yan C, Wang X, Lei T, Yang X et al (2023) Pathological BBB crossing melanin-like nanoparticles as metal-ion chelator and neuroinflammation regulator against Alzheimer\u2019s disease. Research. 6:0180. https:\/\/doi.org\/10.34133\/research.0180","DOI":"10.34133\/research.0180"},{"issue":"2","key":"4256_CR227","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/acs.biomac.0c01290","volume":"22","author":"J Kowalczyk","year":"2021","unstructured":"Kowalczyk J, Grapsi E, Espargaro A, Caballero AB, Ju\u00e1rez-Jim\u00e9nez J, Busquets MA, Gamez P, Sabate R et al (2021) Dual effect of prussian blue nanoparticles on A\u03b240 aggregation: \u03b2-Sheet fibril reduction and copper dyshomeostasis regulation. Biomacromol 22(2):430\u2013440. https:\/\/doi.org\/10.1021\/acs.biomac.0c01290","journal-title":"Biomacromol"},{"issue":"3","key":"4256_CR228","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1039\/C1SC00631B","volume":"3","author":"M Li","year":"2012","unstructured":"Li M, Liu Z, Ren J, Qu X (2012) Inhibition of metal-induced amyloid aggregation using light-responsive magnetic nanoparticle prochelator conjugates. Chem Sci 3(3):868\u2013873. https:\/\/doi.org\/10.1039\/C1SC00631B","journal-title":"Chem Sci"},{"key":"4256_CR229","doi-asserted-by":"publisher","unstructured":"Li M, Shi P, Xu C, Ren J, Qu X (2013) Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H2O2-responsive controlled drug release for potential Alzheimer\u2019s disease treatment. Chem Sci 4(6):2536\u20132542. https:\/\/doi.org\/10.1039\/C3SC50697E","DOI":"10.1039\/C3SC50697E"},{"issue":"41","key":"4256_CR230","doi-asserted-by":"publisher","first-page":"14523","DOI":"10.1002\/chem.201603233","volume":"22","author":"Y Guan","year":"2016","unstructured":"Guan Y, Gao N, Ren J, Qu X (2016) Rationally designed CeNP@ MnMoS4 core-shell nanoparticles for modulating multiple facets of Alzheimer\u2019s disease. Chem - A Eur J 22(41):14523\u201314526. https:\/\/doi.org\/10.1002\/chem.201603233","journal-title":"Chem - A Eur J"},{"issue":"23","key":"4256_CR231","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1039\/C6TB01215A","volume":"4","author":"M Li","year":"2016","unstructured":"Li M, Guan Y, Ding C, Chen Z, Ren J, Qu X (2016) An ultrathin graphitic carbon nitride nanosheet: a novel inhibitor of metal-induced amyloid aggregation associated with Alzheimer\u2019s disease. J Mater Chem B Chem Sci 4(23):4072\u20134075. https:\/\/doi.org\/10.1039\/C6TB01215A","journal-title":"J Mater Chem B Chem Sci"},{"key":"4256_CR232","doi-asserted-by":"publisher","first-page":"120483","DOI":"10.1016\/j.biomaterials.2020.120483","volume":"267","author":"L Gong","year":"2021","unstructured":"Gong L, Zhang X, Ge K, Yin Y, Machuki JOA, Yang Y, Shi H, Geng D et al (2021) Carbon nitride-based nanocaptor: an intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer\u2019s disease. Biomaterials 267:120483. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120483","journal-title":"Biomaterials"},{"key":"4256_CR233","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ejmech.2019.07.031","volume":"180","author":"C Zhang","year":"2019","unstructured":"Zhang C, Yang K, Yu S, Su J, Yuan S, Han J, Chen Y, Gu J et al (2019) Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer\u2019s disease. Eur J Med Chem 180:367\u2013382. https:\/\/doi.org\/10.1016\/j.ejmech.2019.07.031","journal-title":"Eur J Med Chem"},{"issue":"13","key":"4256_CR234","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/bph.13318","volume":"173","author":"O Weinreb","year":"2016","unstructured":"Weinreb O, Amit T, Bar-Am O, Youdim MB (2016) Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and \u03b2-amyloid in ageing and Alzheimer\u2019s disease. British J Pharmacol 173(13):2080\u20132094. https:\/\/doi.org\/10.1111\/bph.13318","journal-title":"British J Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04256-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04256-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04256-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T09:18:52Z","timestamp":1732267132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04256-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":234,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04256-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}